Efficacy, safety, and cost of mobilization strategies in multiple myeloma: a prospective, observational study

Binod Dhakal; Mei-Jei Zhang; Linda J Burns; Xiaoying Tang; Christa Meyer; Lih-Wen Mau; Ajay K Nooka; Edward Stadtmauer; Ivana N Micallef; Joseph McGuirk; Luciano Costa; Mark B Juckett; Nina Shah; Richard E Champlin; Saad Z Usmani; Sherif S Farag; Taiga Nishihori; Vivek Roy; Andrew Bodiford; Yvonne J Barnes; Edward J Drea; Parameswaran Hari; Mehdi Hamadani

doi:10.3324/haematol.2022.282269

Efficacy, safety, and cost of mobilization strategies in multiple myeloma: a prospective, observational study

Haematologica. 2023 Aug 1;108(8):2249-2254. doi: 10.3324/haematol.2022.282269.

Authors

Binod Dhakal¹, Mei-Jei Zhang², Linda J Burns³, Xiaoying Tang³, Christa Meyer⁴, Lih-Wen Mau⁴, Ajay K Nooka⁵, Edward Stadtmauer⁶, Ivana N Micallef⁷, Joseph McGuirk⁸, Luciano Costa⁹, Mark B Juckett¹⁰, Nina Shah¹¹, Richard E Champlin¹², Saad Z Usmani¹³, Sherif S Farag¹⁴, Taiga Nishihori¹⁵, Vivek Roy¹⁶, Andrew Bodiford¹⁷, Yvonne J Barnes¹⁸, Edward J Drea¹⁹, Parameswaran Hari³, Mehdi Hamadani²⁰

Affiliations

¹ BMT and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee.
² Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI; CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee.
³ CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee.
⁴ CIBMTR® (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match, Minneapolis, MN.
⁵ Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA.
⁶ University of Pennsylvania Abramson Cancer Center, Philadelphia, PA.
⁷ Division of Hematology, Mayo Clinic, Rochester, MN.
⁸ Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Cancer Center, Kansas City.
⁹ Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL.
¹⁰ Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN.
¹¹ Division of Hematology-Oncology; University of California San Francisco, San Francisco, CA.
¹² Department of Stem Cell Transplantation and Cellular Therapy, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston.
¹³ Department of Medicine, Memorial Sloan Kettering Cancer Center, New York.
¹⁴ Division of Hematology and Oncology, Indiana University School of Medicine, Indianapolis, IN.
¹⁵ Department of Blood and Marrow Transplant and Cellular Immunotherapy (BMT CI), Moffitt Cancer Center, Tampa, FL.
¹⁶ Blood and Marrow Transplant Program, Mayo Clinic, Jacksonville, FL.
¹⁷ US Medical Affairs - Transplantation, Sanofi, Bridgewater, NJ.
¹⁸ US Medical Affairs - Hematology Oncology, Sanofi Specialty Care, Cambridge, MA.
¹⁹ US Medical - Oncology Medical Value and Outcomes, Sanofi Specialty Care, Cambridge, MA.
²⁰ BMT and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI; CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee. mhamadani@mcw.edu.

No abstract available

Publication types

Observational Study
Letter
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.

MeSH terms

Benzylamines
Granulocyte Colony-Stimulating Factor
Hematopoietic Stem Cell Mobilization
Hematopoietic Stem Cell Transplantation*
Heterocyclic Compounds*
Humans
Multiple Myeloma* / therapy
Prospective Studies
Transplantation, Autologous

Substances

Granulocyte Colony-Stimulating Factor
Heterocyclic Compounds
Benzylamines

Publication types

MeSH terms

Substances

Grants and funding